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Improvement in survival of patients with colon cancer is reduced in elderly patients com-
pared to younger patients. The aim of this study was to investigate whether the removal of
 12 lymph nodes can explain differences in survival rates between elderly and younger
patients diagnosed with colon cancer.
Methods
In a population-based cohort study, all patients (N = 41,074) diagnosed with colon cancer
stage I to III from 2003 through 2010 from the Netherlands Cancer Registry were included.
Age groups were defined as < 66, 66–75 and > 75 years of age. Main outcome measures
were overall and relative survival, the latter as a proxy for disease specific survival.
Results
Over an eight years time period there was a 41.2% increase in patients with 12 lymph
nodes removed, whereas the percentage of patients with the presence of lymph node
metastases remained stable (35.7% to 37.5%). After adjustment for patient and tumour
characteristics and adjuvant chemotherapy, it was found that for patients in which 12
lymph nodes were removed compared to patients with < 12 lymph nodes removed, there
was a statistically significant higher overall survival (< 66: HR: 0.858 (95% CI, 0.789–
0.933); 66–75: HR: 0.763 (95% CI, 0.714–0.814); > 75: HR: 0.734 (95% CI, 0.700–0.771))
and relative survival (< 66: RER: 0.783 (95% CI, 0.708–0.865); 66–75: RER: 0.672 (95%
CI, 0.611–0.739); > 75: RER: 0.621 (95% CI, 0.567–0.681)) in all three age groups.
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Conclusions
The removal of 12 lymph nodes is associated with an improvement in both overall and rel-
ative survival in all patients. This association was stronger in the elderly patient. The biology
of this association needs further clarification.
Introduction
Colon cancer is one of the most common cancers in men and women [1]. Each year, world-
wide, over one million cases are newly diagnosed and approximately 600 000 patients die of
this disease. As the incidence increases with age, colon cancer occurs mainly in patients older
than 65 years of age [2]. In the Netherlands, roughly 70% of patients are in this age group when
diagnosed with colon cancer, with a peak incidence between 70–74 years [3]. Colon cancer sur-
vival has improved over the last few decades. However, this improvement in survival is reduced
in elderly patients compared to younger patients [4,5]. For colon carcinomas the 5-year relative
survival for patients of 75 years and older is 56%, compared to 60% in patients aged 65 to 74
years, and up to 65% in patients younger than 65 years [6].
The presence of nodal metastases at the time of surgical treatment has been found to be the
most important determinant of prognosis in patients with localized colon cancer [7,8]. If there
is nodal involvement in colon cancer, a patient is eligible for adjuvant chemotherapy [9]. Ade-
quate staging of a tumour will lead to the just allocation of adjuvant therapy and improve sur-
vival [10,11]. Given the high local recurrence and mortality in stage II patients with lower
number of removed lymph nodes, adjuvant chemotherapy is also appropriate for these patients
[12]. Although these so called high-risk stage II and stage III patients are eligible for adjuvant
treatment, especially in the elderly patients, the allocation depends on frailty and comorbidity.
The number of removed lymph nodes depends among other things on the size of the resected
specimen (surgeon dependent) and the accuracy of the pathologist. Due to several reasons, the
removal of lymph nodes decreases with age [13].
The aim of this study was to investigate whether the removal of more ( 12) lymph nodes
can explain differences in survival rates between elderly and younger patients diagnosed with
colon cancer.
Methods
Data were retrieved from the Netherlands Cancer Registry (NCR). The NCR has been collect-
ing data on newly diagnosed cancers since 1989. The database contains data on over 95 percent
of patients diagnosed with cancer in the Netherlands. The NCR uses the same code system as
the World Health Organisation (WHO) and the International Association of Cancer Registries
(IACR). Local pathological laboratories collect the pathological data. All these laboratories are
affiliated to the Pathologische Anatomische Landelijke Geautomatiseerd Archief (PALGA), the
nationwide Dutch network and registry of histopathology and cytopathology. The NCR is
based on reports of all newly diagnosed malignancies in the Netherlands by PALGA. The NCR
includes detailed information on patients’ characteristics, year of diagnosis, type of surgery,
tumour characteristics (e.g. tumour location, tumour stage according to the UICC classification
[14], morphology and differentiation grade), treatment, number of removed lymph nodes and
number of lymph node metastases. Tumour location was defined as right-sided including
transversum, left-sided and sigmoid. The sixth edition of TNM classification was used for
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staging the tumour. Patients’ vital status was obtained by linking the NCR to the municipality
register. Follow-up was completed until December 2010. For patients who were still alive, this
date was taken as censoring date; unless the patient emigrated, then the date of emigration was
taken as censoring date.
For this study, data from all patients diagnosed between January 2003 and December 2010
with adenocarcinomas of the colon, stage I-III, and differentiation grade I-III tumours (well—
poorly differentiated), including those with an unknown differentiation grade, were retrieved
(N = 46,322). Excluded were patients with an unknown tumour location (n = 387), unknown
number of removed lymph nodes (n = 1,124), unknown lymph nodal status (n = 31) and
patients for whom the TNM classification did not correspond with the lymph nodal status
(n = 120). Patients who received neo-adjuvant treatment were also excluded (n = 908). After
exclusion 41,074 patients were available for the analysis, see Fig 1.
Fig 1. Flowchart of the in- and exclusion of patients with colon cancer in this analysis. Data were
retrieved from the Netherlands Cancer Registry.
doi:10.1371/journal.pone.0155608.g001
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No approval from a Medical Ethical Committee or Institutional board was needed for this
study, since anonymized and de-identified data were retrieved from the Netherlands Cancer
Registry.
Based on morphology, the tumours were divided into two groups. One group contained
adenocarcinomas and a second group contained mucinous neoplasms. Based on clinical guide-
lines patients were also divided into two groups according to the number of removed lymph
nodes:< 12 and 12. Three patient groups were established based on age at time of diagnosis:
< 66 years, 66–75 years, and> 75 years. These age groups are frequently used in epidemiologi-
cal studies in elderly patients with colon cancer.
Statistics
Patients and clinical and pathological characteristics were presented, as well as changes over
time in the percentage of patients with 12 of more lymph nodes removed per year of diagnosis
and the percentage of patients with lymph node metastases per year of diagnosis stratified for
the three age groups (< 66 years, 66–75 years, and> 75 years). Multivariate logistic regression
analysis was performed to identify the variables that were associated with the removal of 12 or
more lymph nodes.
Survival was estimated by the application of the Kaplan-Meier method for the patients in
which 12 of more lymph nodes were removed versus those in which less than 12 lymph nodes
were removed, stratified by age group and compared using log-rank tests. A multivariate Cox
regression analysis was performed to analyse whether the removal of 12 or more lymph nodes
for given age groups was associated with absolute survival. Therefore these variables were
entered as interaction factors into the analysis. The analysis was adjusted for the covariates
with trend-significant effects (p< 0.10) on the univariate analysis. All these analyses were car-
ried out using SPSS (version 20.0; SPSS Inc, Chicago, III).
Relative survival, an estimation of disease-specific survival, was calculated as the ratio of the
observed rates in cancer patients to expected rates in the general population using the Ederer
method [15]. Relative excess risks (RER) of dying were estimated by means of multivariable rel-
ative survival analyses. STATA (version 14) was used for this analysis.
Results
The median age at time of diagnosis was 72 years (IQR: 63–79; Table 1). Most patients had
stage II cancer (44.7%) followed by 36.9% stage III cancer, and 18.4% stage I cancer.
From 2003 through 2010 the removal of 12 or more lymph nodes increased from 25.8% to
67.1%. The percentage increased from 31.9% to 71.9% for patients younger than 66 years,
from 25.2% to 67.6% in patients aged 66 to 75 years, and from 21.4% to 62.9% in patients
older than 75 years (Fig 2). The percentage of patients diagnosed with lymph node metastases
was rather stable from 2003 through 2010: 41.9% versus 42.1% in patients younger than 66
years, 34.9% to 37.9% in patients aged 66 to 75 years, and 31.2% to 33.6% in patients older
than 75 years (Fig 3).
When analysing trends over time per age group, we found no changes in the location of the
tumour or the stage of tumour. Even so, the percentage of patients per age group receiving che-
motherapy remained stable over the study period. The percentage of patients per age group
with 12 or more lymph nodes that received chemotherapy remained also stable over time.
Patients aged 66 to 75 years and patients older than 75 years, were less likely to have 12 or
more lymph nodes removed, as compared to patients under the age of 66 (respectively OR:
0.718 (95% CI, 0.681–0.757) and OR 0.559 (95% CI, 0.531–0.589))(Table 2).
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Table 1. Patient, clinical and pathological characteristics (N = 41,074).
Characteristics N (%)a
Age median (IQR) 72 (63–79)
< 66 years 12,584 (30.6)
66–75 years 13,088 (31.9)










Mucinous neoplasms 6,730 (16.4)
Differentiation grade
Well differentiated 3,242 (7.9)
Moderately differentiated 28,088 (68.3)












Stage I 7,573 (18.4)
Stage II 18,350 (44.7)
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Overall and relative survival
Overall survival decreased with age and if less than 12 lymph nodes were removed (Fig 4).
Overall 5-year survival rates were 2% higher for patients younger than 66 years when 12 or
more lymph nodes were removed: 81% versus 79%. In patients aged 66 to 75 years this differ-
ence was 5% (71% versus 66%) and in patients older than 75 years there was a 8% difference
(53% versus 45%).
After adjustment for gender, tumour location, tumour morphology, differentiation grade,
tumour invasion, the presence of lymph node metastases, year of diagnosis and adjuvant che-
motherapy, it was found that for patients in which 12 or more lymph nodes were removed
compared to those with less than 12, there was a statistically significant higher overall survival
in all three age groups, (< 66: HR: 0.858 (95% CI, 0.789–0.933); 66–75: HR: 0.763 (95% CI,
0.714–0.814);> 75: HR: 0.734 (95% CI, 0.700–0.771)) (Table 3).
After adjustment for the same patient and tumour characteristics and adjuvant chemother-
apy, it was found that for patients in which 12 or more lymph nodes were removed compared
to those with less than 12, there was a statistically significantly higher relative survival in all age
Fig 2. Patients with 12 or more lymph nodes removed per year of diagnosis, stratified by age groups.
doi:10.1371/journal.pone.0155608.g002
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groups (< 66: RER: 0.783 (95% CI, 0.708–0.865); 66–75: RER: 0.672 (95% CI, 0.611–0.739);>
75: RER: 0.621 (95% CI, 0.567–0.681)) (Table 3).
The benefit in survival in patients with 12 or more lymph nodes was present in both patients
with a right-sided tumour and in patients with a tumour originated from the sigmoid (data not
shown).
Discussion
In this large population-based study of patients operated on colon cancer from 2003 through
2010, we found that over a time period of 8 years there was an increase of about 40% in patients
with 12 or more lymph nodes removed, whereas the percentage of patients with lymph nodes
metastases remained stable over this time period. After adjustment for patient and tumour
characteristics and adjuvant chemotherapy, it was found that for patients in which 12 or more
lymph nodes were removed, there was a statistically significant higher overall and relative sur-
vival in all age groups. This effect was stronger in the elderly.
The National Comprehensive Cancer Network, American Joint Committee on Cancer, and
American College of Pathologist recommend the removal of at least 12 lymph nodes for
Fig 3. Patients diagnosed with lymph nodemetastases per year of diagnosis, stratified by age
groups.
doi:10.1371/journal.pone.0155608.g003
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adequate staging in colon cancer [7,16]. Because there is no clear cut-off point in the literature,
the Dutch guidelines state that the removal of 10 or more lymph nodes is sufficient for ade-
quate staging [17]. However, they also state that all the lymph nodes in a specimen should be
evaluated. The initial rational is that the removal of more lymph nodes will improve accurate
staging, so that more patients can benefit from adjuvant therapy [11,18]. Though the removal
of less than 12 lymph nodes is not uncommon [13,19,20]. In accordance with our results, mul-
tiple studies show that there is an increase over time in the number of lymph nodes removed,
whereas the number of patients diagnosed with lymph nodal metastases remains the same
Table 2. Factors associated with the removal of 12 or more lymph nodes in patients with colon cancer
(N = 41,074); multivariate logistic regression analysis.
Characteristics OR (95% Cl) p
Age
< 66 years 1 < 0.001
66–75 years 0.718 (0.681–0.757) < 0.001
> 75 years 0.559 (0.531–0.589) < 0.001
Gender
Men 1
Female 1.057 (1.013–1.102) 0.011
Tumour location
Right (+ transversum) 1 < 0.001
Left 0.560 (0.518–0.606) < 0.001
Sigmoid 0.577 (0.551–0.604) < 0.001
Morphology
Adenocarcinomas 1
Mucinous neoplasms 1.015 (0.958–1.076) 0.615
Differentiation grade
Well differentiated 1 0.006
Moderately differentiated 1.082 (1.000–1.171) 0.051
Poorly differentiated 1.082 (0.986–1.188) 0.098
Unknown 0.950 (0.854–1.058) 0.351
Tumour invasion
T1 1 < 0.001
T2 2.450 (2.189–2.744) < 0.001
T3 4.002 (3.603–4.446) < 0.001
T4 3.626 (3.221–4.082) < 0.001
N status
N0 1 < 0.001
N1 0.918 (0.873–0.965) 0.001
N2 1.770 (1.652–1.897) < 0.001
Year of diagnosis
2003 1 < 0.001
2004 1.279 (1.163–1.406) < 0.001
2005 1.863 (1.699–2.042) < 0.001
2006 2.501 (2.286–2.737) < 0.001
2007 3.420 (3.127–3.740) < 0.001
2008 3,832 (3.505–4.191) < 0.001
2009 5.425 (4.958–5.936) < 0.001
2010 6.661 (6.076–7.302) < 0.001
doi:10.1371/journal.pone.0155608.t002
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[21–24]. Currently the percentage of patients with 10 or more lymph nodes removed and 12 or
more lymph nodes removed in the Netherlands is approximately 83% and 73% respectively,
and thereby stable over the last years. Although there is no significant association between a
higher number of removed lymph nodes and the detection of lymph node metastases, a higher
number of removed lymph nodes is associated with improved relative survival [21]. An
improvement in both overall and disease specific survival when more lymph nodes are
removed was also reported in a systematic review from Chang et al [25]. These results suggest a
more accurate staging is not the primary explanation for improved survival in patients with
more lymph nodes removed.
In general an increased awareness amongst surgeons and pathologists resulted in a more dil-
igence approach in the removal of more lymph nodes in colon cancer. Previous studies showed
a large variation in adequate lymph node removal and evaluation between hospitals, suggesting
differences in efforts of the surgeons and pathologists [13, 26]. They found that academic hos-
pitals and pathology laboratories report a higher number of removed lymph nodes. Increased
awareness as a result of feedback to surgeons and pathologists in multidisciplinary working
Fig 4. Survival in patients in all age groups with colon cancer stratified by the number of removed
lymph nodes. *Log-rank: 3.573, p = 0.059; **Log-rank: 34.937, p < 0.001; ***Log-rank: 100.427, p < 0.001.
doi:10.1371/journal.pone.0155608.g004
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groups may have contributed in the increase in number of removed lymph nodes per year of
diagnosis [27]. At last, differences in the number of removed lymph nodes could be explained
by differences in pathology reports between pathology laboratories [26,28].
Nevertheless, the increase in the number of removed lymph nodes corresponds with the
improvement in survival in the past decades [29]. The removal of more lymph nodes is also
important for other prognostic variables like the ratio between number of removal lymph
nodes and the number of lymph node metastasis (lymph node ratio). Recently several studies
demonstrated their important prognostic role in the prediction of survival in colon cancer.
However the role of age is still underexposed [30,31].
In contrast to other studies, we focused on the role of age on the removal of lymph nodes
and the improvement in survival in the past decade. We found that in all age groups there is a
significant improvement in both overall and relative survival when 12 or more lymph nodes
were removed compared to when less than 12 lymph nodes were removed. This effect was also
observed in two other large studies [32,33]. Although both studies reported an overall survival
benefit in elderly patients when 12 or more lymph nodes were removed, these results were not
adjusted for confounding patient and tumour characteristics and adjuvant chemotherapy. As
such, bias by indication could not be excluded in these two studies. Even so, these studies did
not present data on relative survival.
The significant improvement in survival when 12 or more lymph nodes were removed was
strongest in the elderly patients, both in the survival analyses and the adjusted analyses. An
interesting question is how to explain the larger overall and relative survival benefit we found
in patients over 75 years of age. One explanation is that patients over 75 years of age form a
large and heterogeneous group varying from robust, physically active and mentally intact
individuals, to those who are cognitively impaired and suffer from multiple chronic morbidi-
ties [34]. It might be that vital elderly patients undergo a more extensive resection that results
in the removal of more lymph nodes. As we have no information on comorbidity and func-
tional status of the patients included in this database, we could not adjust for these patient
characteristics. Another explanation is the postulation that a more extensive removal of
lymph nodes results in the removal of micrometastases [35]. Lymph nodes with the presence
of micrometastases (0.2–2mm) are considered to be node negative according to the Dutch
Table 3. The impact of the number of removed lymph nodes on overall and relative survival in all age
groups (N = 41,074)a.
Characteristic Overall survival Relative survival
HR (95%CI)b RER (95% CI)b
< 66 years
< 12 lymph nodes 1 1
 12 lymph nodes 0.858 (0.789–0.933) 0.783 (0.708–0.865)
66–75 years
< 12 lymph nodes 1 1
 12 lymph nodes 0.763 (0.714–0.814) 0.672 (0.611–0.739)
> 75 years
< 12 lymph nodes 1 1
 12 lymph nodes 0.734 (0.703–0.774) 0.621 (0.567–0.681)
aAdjusted for gender, tumour location, tumour morphology, differentiation grade, tumour invasion, the
presence of lymph node metastases, year of diagnosis and adjuvant chemotherapy.
bp < 0.001
doi:10.1371/journal.pone.0155608.t003
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guidelines [36]. However, the presence of micrometastases has recently been associated with
local recurrence and decrease in survival [37,38]. Therefore a more extensive resection might
improve survival.
It is suggested that a more robust immune reaction could lead to improved survival [39,40].
The number of lymph nodes decreases with age, partially due to involution of lymph nodes
[13,41]. However, a less pronounced anti tumour response is also observed in elderly patients
[42,43]. Patients who mount a stronger immune response to their cancers may have larger and
hence easier detectable lymph nodes in their resected mesentery. Therefore the survival benefit
we found might be attributed to the patients’ health and vitality.
The elderly tend to have more right-sided tumours [44]. Our results confirm this. Right-
sided tumours are associated with a worse prognosis when compared to left-sided tumours
[45]. Although the elderly tend to have a prognostic worse tumour, the removal of more lymph
nodes leads to an increase in survival in the elderly. During our study period there were no
changes in location of the tumour.
Because bowel screening programs were only introduced in 2013, and during our study
period there were only a few trials regarding bowel screening, these programs hardly influenced
our results. Remarkably, despite the absence of bowel screening programs, our database con-
tained a higher proportion of stage II cancers compared to stage III. Which was also reported
by another population-based study in the Netherlands [46].
The percentage of patients per age group receiving chemotherapy during our study period
remained stable. Also when dividing these patients within these age groups in patients with less
than 12 and 12 or more lymph nodes, the percentage of patients that received chemotherapy
remained stable over time for both categories. Therefore the influence of chemotherapy on the
improvement in survival in patients with 12 or more lymph nodes is limited.
Although our study provides more insight into the relationship between age, number of
removed lymph nodes and survival in a population-based setting, we acknowledge several data
related limitations. Data were derived from a cancer registry, in which no data were available
on comorbidity and functional status of the patient. No data were available on laparoscopic
versus open and elective versus emergency procedures. Also no data were available on type,
duration or completion of chemotherapy. Finally, no data were available on the presence of
micrometastases in node negative cancers and on microsatellite (in) stability of a tumour.
Recently microsatellite instability is related to high lymph node retrieval in colon cancer and is
present in approximately 15% of all colon tumours [47]. All these unmeasured confounders
might have biased our findings.
Conclusion
In colon cancer, the removal of lymph nodes increased over an eight years time period, whereas
the percentage of patients with lymph nodes metastases remained stable over this time period.
The removal of 12 or more lymph nodes leads to an improvement in both overall and relative
survival in all patients. This effect was independent from patient and tumour characteristics
and adjuvant chemotherapy and was stronger in elderly patients. The biology behind this asso-
ciation is multifactorial and needs further clarification. The survival benefit may be the conse-
quence of the performance of more extensive surgery on relatively healthy and vital elderly
patients. However, also tumour and patients biology might play an important role.
Author Contributions
Analyzed the data: WBS BLL MAGE GHB. Wrote the paper: WBS BLL MAGE GHB.
Lymph Node Retrieval and Survival in the Elderly
PLOS ONE | DOI:10.1371/journal.pone.0155608 May 19, 2016 11 / 14
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer
in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893–2917. doi: 10.1002/ijc.25516 PMID:
21351269
2. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, Forman D. Fifty years of cancer inci-
dence: CI5 I-IX. Int J Cancer. 2010; 127: 2918–1927. doi: 10.1002/ijc.25517 PMID: 21351270
3. Nederlandse Kankerregistratie, 12–14. Available: http://www.cijfersoverkanker.nl/selecties/dataset_1/
img54569f7ad840e.
4. Mitry E, Bouvier AM, Esteve J, Faivre J. Improvement in colorectal cancer survival: A population-based
study. Eur J Cancer. 2005; 41: 2297–2303. PMID: 16140008
5. Van Leeuwen BL, Påhlman L, Gunnarsson U, Sjövall A, Martling A. The effect of age and gender on
outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm
region. Crit Rev Oncol Hematol. 2008; 67: 229–236. doi: 10.1016/j.critrevonc.2008.03.005 PMID:
18440820
6. Nederlandse Kankerregistratie, 12–14. Available: http://www.cijfersoverkanker.nl/selecties/dataset_1/
img5456a0b69bc04?type=bar.
7. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in
colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med.
2000; 124: 979–994. PMID: 10888773
8. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. Guidelines 2000 for colon and
rectal cancer surgery. J Natl Cancer Inst. 2001; 93: 583–596. PMID: 11309435
9. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer
J Clin. 2007; 57: 168–185. PMID: 17507442
10. Goldstein NS, SanfordW, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection speci-
mens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of
lymph nodes to be recovered. Am J Clin Pathol. 1996; 106: 209–216. PMID: 8712176
11. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: Impli-
cations of race/ethnicity, age, and differentiation. JAMA. 2005; 294: 2703–2711. PMID: 16333005
12. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society
of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin
Oncol. 2004; 22: 3408–3419. PMID: 15199089
13. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in
colorectal cancer patients: A population-based study. J Natl Cancer Inst. 2005; 97: 219–225. PMID:
15687365
14. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH. TNM atlas: Illustrated guide to the TNM/
pTNM classification of malignant tumours. 5th ed. Berlin. New York, Springer; 2004.
15. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. National
Cancer Institute, Bethesda, MD; 1959.
16. NCCN clinical practice guidelines in oncology. Colon cancer. Update 3/15. 8–15. Available: http://www.
nccn.org/professionals/physician_gls/pdf/colon.pdf.
17. Landelijke werkgroep Gastro Intestinale Tumoren, landelijke richtlijn. Update 4/14. 2/16. Available:
http://www.oncoline.nl/colorectaalcarcinoom.
18. Van Steenbergen LN, Elferink MAG, Lemmens VEPP, Siesling S, Rutten HJ, Richel DJ, et al. Improved
survival of colon cancer due to improved treatment and detection: A nationwide population-based study
in the Netherlands 1989–2006. Ann Oncol. 2010; 21: 2206–2212. doi: 10.1093/annonc/mdq227 PMID:
20439339
19. Bilimoria KY, Bentrem DJ, Stewart AK, Talamonti MS, Winchester DP, Russell TR, Ko CY. Lymph
node evaluation as a colon cancer quality measure: A national hospital report card. J Natl Cancer Inst.
2008; 100: 1310–1317. doi: 10.1093/jnci/djn293 PMID: 18780863
20. Elferink MAG, Siesling S, Visser O, Rutten HJ, Van Krieken JHJM, Tollenaar RAEM, Lemmens VEPP.
Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer
and its impact on survival, a nationwide population-based study in the Netherlands. Ann Oncol, 2011;
22: 110–117. doi: 10.1093/annonc/mdq312 PMID: 20595447
21. Parsons HM, Tuttle TM, Kuntz KM, Begun Jw, McGovern PM, Virnig BA. Association between lymph
node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011; 306: 1089–
1097. doi: 10.1001/jama.2011.1285 PMID: 21917579
Lymph Node Retrieval and Survival in the Elderly
PLOS ONE | DOI:10.1371/journal.pone.0155608 May 19, 2016 12 / 14
22. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and
patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol.
2006; 93: 439–445. PMID: 16615148
23. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination
rates and survival after resection for colon cancer. JAMA. 2007; 298: 2149–2154. PMID: 18000198
24. O'Shea A, Aly O, Parnaby CN, Loudon MA, Samuel LM, Murray GI. Increased lymph node yield in colo-
rectal cancer is not necessarily associated with a greater number of lymph node positive cancers.
PLoS One. 2014 9(8): e104991. doi: 10.1371/journal.pone.0104991 PMID: 25118594
25. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. Lymph node evaluation and survival after curative
resection of colon cancer: Systematic review. J Natl Cancer Inst. 2007; 99: 433–441. PMID: 17374833
26. Elferink MAG, Siesling S, Visser O, Rutten HJ, Van Krieken JHJM, Tollenaar RAEM, Lemmens VEPP.
Large variation between hospitals and pathology laboratories in lymph node evaluation in colon cancer
and its impact on survival, a nationwide population-based study in The Netherlands. Ann Oncol. 2011;
22: 110–117. doi: 10.1093/annonc/mdq312 PMID: 20595447
27. Van Steenbergen LN, Van Lijnschoten G, Rutten HJ, Lemmens VEPP, Coebergh JWW. Improving
lymph node detection in colon cancer in community hospitals and their pathology department in south-
ern Netherlands. Eur J Surg Oncol. 2010; 36: 145–140.
28. Jestin P, Påhlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colon cancer is depen-
dent on the quality of the pathologists' specimen examination. Eur J Cancer. 2005; 41: 2071–207.
PMID: 16125926
29. Van Erning FN, Crolla RM, Rutten HJ, Beerepoot LV, Van Krieken JH, Lemmens VEPP. No change in
lymph node positivity rate despite increased lymph node yield and improved survival in colon cancer.
Eur J Cancer. 2014; 50: 3221–3229. PMID: 25459398
30. Parnaby CN, Scott NW, Ramsay G, MacKay C, Samuel L, Murray GI, Loudon MA. Prognostic value of
lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon
resection. Br J Cancer. 2015; 113:212–219. doi: 10.1038/bjc.2015.211 PMID: 26079302
31. Rosenberg R, Engel J, Bruns C, HettlandW, Hermes N, Jauch KW, et al. The prognostic value of
lymph node ratio in a population-based collective of colorectal patients. Ann Surg. 2010; 251:1070–
1078. doi: 10.1097/SLA.0b013e3181d7789d PMID: 20485149
32. Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS, Ko CY. Adequacy and importance of
lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008; 206: 247–254. doi: 10.
1016/j.jamcollsurg.2007.07.044 PMID: 18222376
33. Steele SR, Chen SL, Stojadinovic A, Nissan A, Zhu K, Peoples GE, Bilchik A. The impact of age on
quality measure adherence in colon cancer. J Am Coll Surg. 2011; 213:95–105. doi: 10.1016/j.
jamcollsurg.2011.04.013 PMID: 21601492
34. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME. Multimorbidity and survival in older per-
sons with colorectal cancer. J AmGeriatr Soc. 2006; 54: 1898–1904. PMID: 17198496
35. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, et al. Prognosis of patients with
colorectal cancer is associated with lymph node ratio: A single-center analysis of 3,026 patients over a
25-year time period. Ann Surg. 2008; 248: 968–978. doi: 10.1097/SLA.0b013e318190eddc PMID:
19092341
36. Handleiding protocol colonrectum (3.0.25), update 6/15. 8–15. Available: http://www.palga.nl/palga/
palgacms.nsf/uploads/E0AB613234F32E0DC1257D800040DF60/$FILE/Documentatie%
20ColonRectumProtocol%20(3.0.26)%20V26.pdf.
37. Rahbari NN, Bork N, Motschall E, Thorlund K, Büchler MW, Koch M, Weitz J. Molecular detection of
tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-
negative colorectal cancer: A systematic review and meta-analysis. J Clin Oncol. 2012; 30: 60–70. doi:
10.1200/JCO.2011.36.9504 PMID: 22124103
38. Sloothaak DA, Sahami S, Van der Zaag-Loonen HJ, Van der Zaag ES, Tanis PJ, BemelmanWA, Bus-
kens CJ. The prognostic value of micrometastases and isolated tumour cells in histologically negative
lymph nodes of patients with colorectal cancer: A systematic review and meta-analysis. Eur J Surg
Oncol. 2014; 40: 263–269. doi: 10.1016/j.ejso.2013.12.002 PMID: 24368050
39. Kim YW, Jan KM, Jung DH, Cho MY, Kim NK. Histological inflammatory cell infiltration is associated
with number of lymph nodes retrieved in colorectal cancer. Anticancer Res. 2013; 33: 5143–5150.
PMID: 24222162
40. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells,
early metastasis, and survival in colorectal cancer. N Engl J Med. 2005; 353: 2654–2666. PMID:
16371631
Lymph Node Retrieval and Survival in the Elderly
PLOS ONE | DOI:10.1371/journal.pone.0155608 May 19, 2016 13 / 14
41. Murphy J, Pocard M, Jass JR, O'Sullivan GC, Lee G, Talbot IC. Number and size of lymph nodes recov-
ered from dukes B rectal cancers: Correlation with prognosis and histologic antitumor immune
response. Dis Colon Rectum. 2007; 50: 1526–1536. PMID: 17828403
42. Anisimov VN, Sikora E, Pawelec G. Relationship between cancer and aging: A multilevel approach.
Biogerontology. 2009; 10: 232–238.
43. Hegde UP, Chakroborty N, Kerr P, Grant-Kels JM. Melanoma in the elderly patient: Relevance of the
aging immune system. Clin Dermatol. 2009; 27: 537–544. doi: 10.1016/j.clindermatol.2008.09.012
PMID: 19880041
44. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with
right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and sur-
vival. Dis Colon Rectum. 2010; 53: 57–64. doi: 10.1007/DCR.0b013e3181c703a4 PMID: 20010352
45. Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M. The worse prognosis of right-sided compared with
left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016; 20: 648–
655. doi: 10.1007/s11605-015-3026-6 PMID: 26573851
46. Elferink MAG, Wouters MWJM, Krijnen P, Lemmens VEPP, Jansen-Landheer MLEA, Van de Velde
CJH, et al. Disparities in quality of care for colon cancer between hospitals in the Netherlands. EJSO.
2010; 36:64–73.
47. Belt EJ, Te Velde EA, Krijgsman O, Brosens RP, Tijssen M, Van Essen HF, et al. High lymph node
yield is related to microsatellite instability in colon cancer. Ann Surg Oncol. 2012; 19:1222–30. doi: 10.
1245/s10434-011-2091-7 PMID: 21989661
Lymph Node Retrieval and Survival in the Elderly
PLOS ONE | DOI:10.1371/journal.pone.0155608 May 19, 2016 14 / 14
